urinary%20incontinence%20in%20women
URINARY INCONTINENCE IN WOMEN
Urinary incontinence is the complaint of involuntary urine leakage.
Stress urinary incontinence is the involuntary urine leakage on effort or exertion or when coughing or sneezing.
Urge urinary incontinence is the one associated with or immediately preceded by urgency.
Mixed urinary incontinence is the involuntary urine leakage associated with both urgency and with exertion, effort, coughing or sneezing.

Specialist Referral

Consider immediate referral to a specialist in the following conditions:
  • Incontinence with abdominal and/or pelvic pain
  • Hematuria in the absence of an infection
  • Suspected fistula
  • Complex neurological conditions (eg Parkinson’s disease, spinal cord injury)
  • Abnormal findings (eg pelvic mass or symptomatic organ prolapse beyond the hymen)
Consider elective referral to a specialist in the following conditions:
  • Persistent symptoms after an adequate therapeutic trial
  • Uncertain diagnosis and lack of reasonable treatment plan
  • Significant increase in PVRV that does not resolve after treatment of possible precipitants (eg medications, stool impaction)
  • Prior pelvic surgery or pelvic irradiation
  • Desire for surgical treatment
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Harriet Pugsley, MB ChB, MRCOG; Judith Moore, MRCOG, 01 Aug 2013

Most women presenting with complications in early pregnancy are assessed, diagnosed and managed at early pregnancy assessment units (EPAUs). These units aim to provide thorough assessments, access to specialist investigations (scan, human chorionic gonadotrophin [hCG]), a rapid turnaround of results, and co-ordination of further management.

07 Aug 2016
Pravastatin supplementation is associated with improved pregnancy outcomes among women with refractory obstetric antiphospholipid syndrome (APS) who developed preeclampsia (PE) or intrauterine growth restriction (IUGR) during standard antithrombotic therapy, according to a study.
Roshini Claire Anthony, 07 Sep 2016

Estrogen receptor α (ESR1) mutations Y537S and D538G are associated with reduced overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer, according to findings of a secondary analysis of the BOLERO-2* clinical trial.